Viewing Study NCT01442259


Ignite Creation Date: 2025-12-24 @ 2:44 PM
Ignite Modification Date: 2026-05-26 @ 10:15 PM
Study NCT ID: NCT01442259
Status: COMPLETED
Last Update Posted: 2020-12-08
First Post: 2011-09-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open-label, Parallel-group Study to Determine the Pharmacokinetics of a Single Dose of AFQ056 in Subjects With Renal Impairment Compared to Healthy Subjects
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Mild Moderate View
None or Severe Renal Impairment View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Renal impairment, View
None pharmacokinetics, View
None safety View